The financial trajectory of 7 Figure Fall: The Rise And Crash Of Elizabeth Holmes’ has become a major talking point in April 2026. 7 Figure Fall: The Rise And Crash Of Elizabeth Holmes’ Net Worth in 2026 reflects a significant expansion in the industry.
The Billion-Dollar Bubble: The Rise And Fall of Elizabeth Holmes and Theranos’ Total Wealth
It wasn’t until 2015, when the Wall Street Journal published a series of exposés revealing the truth about Theranos’ technology, that the company’s house of cards began to crumble.
But the damage was done. Investors began to flee, and the company’s valuation plummeted to almost zero. In 2018, Theranos was shut down, and Holmes was charged with multiple counts of wire fraud and conspiracy.
The WSJ’s reporting was just the beginning of the end for Theranos. The Securities and Exchange Commission (SEC) launched an investigation into the company’s activities, and in 2016, Holmes was forced to step down as CEO.
From its inception in 2003 to its eventual demise in 2018, Theranos’ story is a cautionary tale of the dangers of unchecked ambition, the power of hype, and the importance of regulatory oversight.
So, what drove the company’s skyrocketing valuation, and how did it ultimately come crashing down? Let’s take a closer look at the rise and fall of Elizabeth Holmes and Theranos.
Imagine a world where a single company’s valuation soars to over $9 billion, only to plummet to near zero, leaving investors and employees devastated. Welcome to the wild ride that was Theranos, the blood-testing startup founded by Elizabeth Holmes, whose meteoric rise and catastrophic fall has captivated the business world.
The hype machine was in full gear, with stories of Theranos’ supposed breakthroughs and Holmes’ genius being splashed across the covers of major publications. The company’s valuation soared, reaching $9 billion in 2015.
The company quickly gained traction, with investors and media outlets clamoring for a piece of the action. Holmes’ charismatic personality and futuristic-sounding technology captivated the public, and Theranos became one of the most promising startups in Silicon Valley.
Despite this, Holmes and her team continued to tout the benefits of their technology, often using fake data and misleading presentations to convince investors and partners of its efficacy.
But behind the scenes, Theranos’ technology was far from revolutionary. In reality, the company’s devices were often faulty and unreliable, and the blood tests they produced were frequently inaccurate.
In 2010, Elizabeth Holmes, a 20-year-old Stanford dropout, founded Theranos with the goal of revolutionizing healthcare by making lab testing more accessible and affordable. Her vision was to create a device that could run thousands of tests on just a few drops of blood, using a proprietary technology she called “nanotechnology.”
Data updated: April 2026.
